Neutral
GlobeNewsWire
2 days ago
Rezolute to Participate in Upcoming Investor Conferences
REDWOOD CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will participate in the following investor conferences: Event: Maxim Growth Summit Date: October 22-23, 2025 Event: Guggenheim 2nd Annual Healthcare Innovation Conference Date: November 10-12, 2025 Event: Jefferies London Healthcare Conference Date: November 17-20, 2025 Management will be participating in one-on-one investor meetings throughout the conferences.